Shanghai Rendu Biotechnology Co., Ltd. (SHA:688193)

China flag China · Delayed Price · Currency is CNY
61.67
+2.79 (4.74%)
At close: Apr 29, 2026
76.70%
Market Cap 2.39B
Revenue (ttm) 161.94M
Net Income (ttm) 10.09M
Shares Out 38.78M
EPS (ttm) 0.26
PE Ratio 237.19
Forward PE n/a
Dividend 0.30 (0.51%)
Ex-Dividend Date Nov 26, 2025
Volume 1,444,226
Average Volume 747,976
Open 58.92
Previous Close 58.88
Day's Range 57.21 - 63.01
52-Week Range 34.54 - 63.01
Beta 0.32
RSI 70.33
Earnings Date Apr 29, 2026

About SHA:688193

Shanghai Rendu Biotechnology Co., Ltd. engages in the research, development, production, and sales of RNA molecular diagnostic technology and products. It offers products in the areas of reproductive health, bloodborne infections, respiratory infections, enterovirus infections, cancer early detection, and other areas; and AutoSAT, SuperSAT, and ultrasonic homogenizer. The company was founded in 2007 and is based in Shanghai, China. [Read more]

Sector Healthcare
Founded 2007
Employees 290
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688193
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.